| Financial Year |
March 31 2023 |
| Monetary Funds |
5,686,638,410.47 |
| Held-for-trading Financial Assets |
7,807,848,273.29 |
| Notes Receivable |
132,792,749.93 |
| Accounts Receivable |
8,653,071,827.01 |
| Advances to Suppliers |
324,374,776.00 |
| Other Receivables |
441,983,189.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
153,945,889.44 |
| Inventories |
6,503,146,781.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,632,309,666.66 |
| Other Current Assets |
2,099,610,922.73 |
| Total Current Assets |
40,707,710,185.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,637,560,146.29 |
| Investment Properties |
199,767,166.32 |
| Fixed Assetes |
5,237,972,291.40 |
| Under-construction Projects |
668,874,157.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,425,667,105.41 |
| R&D expenses |
-- |
| Goodwill |
226,408,877.76 |
| Long-Term Deferred and Prepaid Expenses |
40,886,671.57 |
| Deferred Income Tax Assets |
983,129,098.86 |
| Other Non-Current Assets |
8,100,647,772.34 |
| Sub-Total of Non-Current Assets |
18,765,921,122.90 |
| Total Assets |
59,473,631,308.87 |
| Short-Term Loans |
1,928,890,525.46 |
| Trading Financial liabilities |
21,089,897.59 |
| Notes Payable |
11,744,320,656.43 |
| Accounts Payable |
10,780,430,892.07 |
| Accounts Received In Advance |
4,085,851.44 |
| Employee Compensation Payable |
818,770,109.15 |
| Taxes Payable |
853,825,258.06 |
| Interest Payable |
-- |
| Dividend Payable |
67,374,222.13 |
| Other payables |
4,919,991,567.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
141,063,512.90 |
| Other Current Liabilities |
6,925,737,600.77 |
| Sub-Total of Current Liabilities |
40,008,126,519.31 |
| Long-term Loans |
32,760,051.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,314,310,626.13 |
| Deferred Income Tax Liabilities |
168,735,501.51 |
| Other Non-Current Liabilities |
696,280,395.65 |
| Sub-Total of Non-Current Liabilities |
2,730,158,767.51 |
| Total Liabilities |
42,738,285,286.82 |
| Paid-In Capital(Or Share Stock) |
1,362,725,370.00 |
| Capital Surplus |
2,090,216,706.03 |
| Surplus Reserve |
711,971,309.99 |
| LESS:Treasury Stock |
211,401,111.66 |
| Undistributed Profits |
7,863,421,193.82 |
| Minority Stockholder's Interest |
4,738,766,608.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,996,579,413.35 |
| Owner's Equity（Stockholder's Equity） |
16,735,346,022.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
59,473,631,308.87 |
